A short-term economic evaluation of early insulin therapy compared to oral anti-diabetic drugs in order to reduce the major adverse events in type 2 diabetes patients in Iran
CONCLUSION: In terms of cost-effectiveness, early insulin therapy was not cost-effective compared to OADs for managing newly diagnosed T2DM patients. Future studies in this regard, utilizing more comprehensive evidence, can yield more accurate results.PMID:38533582 | DOI:10.1080/03007995.2024.2333425
Source: Current Medical Research and Opinion - Category: Research Authors: Ramin Heshmat Ali Darvishi Ramin Abdi Dezfouli Adeleh Nikkhah Ramin Radmanesh Elham Moslemi Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Insulin | Iran Health | Middle East Health | Research | Study